Mohammad Haj Dezfulian

Title: Innovations of Mohammad Haj Dezfulian

Introduction

Mohammad Haj Dezfulian is a notable inventor based in Boston, MA. He has made significant contributions to the field of immunology through his innovative research and patented technologies. With a total of 2 patents, his work focuses on methods and compositions for identifying immune cell-specific antigens.

Latest Patents

His latest patents include "Methods and compositions for identifying epitopes." This patent describes methods for identifying immune cell-specific antigens and compositions for use in these methods. Another patent under his name is also titled "Methods and compositions for identifying epitopes." This patent details antigen presenting cells (APCs) that comprise an exogenous nucleic acid encoding one or more candidate antigens. These candidate antigens are expressed and presented with MHC class I or MHC class II molecules. Additionally, it includes a molecular reporter of Granzyme B (GzB) activity and an exogenous inhibitor of caspase-activated deoxyribonuclease (CAD)-mediated DNA degradation.

Career Highlights

Mohammad Haj Dezfulian is affiliated with Brigham and Women's Hospital, Inc., where he continues to advance his research in immunology. His work has garnered attention for its potential applications in understanding immune responses and developing therapeutic strategies.

Collaborations

He has collaborated with esteemed colleagues such as Stephen J. Elledge and Tomasz Kula, contributing to a rich environment of innovation and discovery.

Conclusion

Mohammad Haj Dezfulian's contributions to the field of immunology through his patents and research at Brigham and Women's Hospital, Inc. highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in understanding immune cell interactions and potential therapeutic applications.